Diazenecarboxamide-extended platinum complexes are hybrid compounds with potential dual targeting against tumor cells combining the advantages of diazene-carboxamide and cisplatin or carboplatin structural motifs. More details are presented by Osmak, Košmrlj et al. p. 368.